- Home
- ALTI vs AUTL Comparison
ALTI vs AUTL Comparison
Compare ALTI & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTI
- AUTL
- Stock Information
- Founded
- ALTI 2020
- AUTL 2014
- Country
- ALTI United States
- AUTL United Kingdom
- Employees
- ALTI N/A
- AUTL N/A
- Industry
- ALTI Investment Managers
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALTI Finance
- AUTL Health Care
- Exchange
- ALTI Nasdaq
- AUTL Nasdaq
- Market Cap
- ALTI 388.9M
- AUTL 433.8M
- IPO Year
- ALTI N/A
- AUTL 2018
- Fundamental
- Price
- ALTI $3.89
- AUTL $1.46
- Analyst Decision
- ALTI
- AUTL Strong Buy
- Analyst Count
- ALTI 0
- AUTL 5
- Target Price
- ALTI N/A
- AUTL $9.12
- AVG Volume (30 Days)
- ALTI 100.4K
- AUTL 2.9M
- Earning Date
- ALTI 11-10-2025
- AUTL 11-13-2025
- Dividend Yield
- ALTI N/A
- AUTL N/A
- EPS Growth
- ALTI N/A
- AUTL N/A
- EPS
- ALTI N/A
- AUTL N/A
- Revenue
- ALTI $217,760,000.00
- AUTL $29,934,000.00
- Revenue This Year
- ALTI $19.78
- AUTL $641.63
- Revenue Next Year
- ALTI $7.00
- AUTL $109.21
- P/E Ratio
- ALTI N/A
- AUTL N/A
- Revenue Growth
- ALTI N/A
- AUTL 185.17
- 52 Week Low
- ALTI $2.33
- AUTL $1.11
- 52 Week High
- ALTI $5.00
- AUTL $4.69
- Technical
- Relative Strength Index (RSI)
- ALTI 57.69
- AUTL 45.67
- Support Level
- ALTI $3.74
- AUTL $1.51
- Resistance Level
- ALTI $4.02
- AUTL $1.67
- Average True Range (ATR)
- ALTI 0.14
- AUTL 0.10
- MACD
- ALTI 0.04
- AUTL -0.01
- Stochastic Oscillator
- ALTI 88.71
- AUTL 7.02
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.